Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-04-15

Clinical Trial Update: Bilateral Comparison Study of Elidel 1% and Hylatopic Plus Emollient Foam for the Treatment of Subjects With Atopic Dermatitis [Phase 4]

View source ↗

Summary

Phase 4 bilateral comparison study evaluating Elidel 1% cream versus Hylatopic Plus Emollient Foam for atopic dermatitis (eczema) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Elidel 1% (pimecrolimus)
  • Hylatopic Plus Emollient Foam

Snippet

Sponsor: Frankel, Amylynne, M.D. | Conditions: Eczema, Atopic Dermatitis | Phase 4 | Status: COMPLETED